Frequency and clinical features of BRAF mutations among patients with stage III/IV lung adenocarcinoma without EGFR/ALK aberrations
published in: OncoTargets and Therapy
date of publication: 2019-07-26
Cites articles 33
- 2019-01-08
- 2002-06-27
Date
Title
Article - wd:Q92798844